We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

3 cheap FTSE 100 stocks to buy and hold for 10 years 

These FTSE 100 stocks are not the cheapest, but they are cheaper than many other index constituents. And they have also given great returns over time. 

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Cheap stocks are getting incredibly hard to come by among FTSE 100 constituents. As the stock markets stay buoyant, share prices are rising fast too. But there are still some stocks that can be seen as relatively cheap. To figure out which ones these are, I first consider the price-to-earnings (P/E) ratio for the FTSE 100 index as a whole. This is around 20 times. 

Many of the stocks that are performing well right now have P/Es well over this level. But there are some around that have lower P/Es too. This is important, because it suggests that these stocks could be undervalued compared to the average FTSE 100 stock. This in turn means that their share prices could rise in the near future. 

Should you buy Hikma Pharmaceuticals Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Hikma Pharmaceuticals: beaten down FTSE 100 stock

One such stock is the pharmaceuticals company Hikma Pharmaceuticals. It has a P/E of 15.2 times, which is not terribly low, but is still lower than average. This leaves some room for growth. But I believe that there could be even more upside considering that it has just delivered robust results.

Moreover, its share price has come off in the past year. As I write, it is down by more than 12% from the same time last year. I think this is a good reason to buy the stock, which has given some 300% return over the last 10 years, albeit with a fair bit of fluctuation in the intervening period. It is definitely a stock on my wish list right now. 

Persimmon: attractive dividend yields

The FTSE 100 house builder Persimmon has a similar story. It has a relatively low P/E of 11.2 times, at least partly because its share price has gone nowhere in the past year. In fact, it has shown a small decline. But over the past decade, it has been an excellent stock to hold. It has grown by more than 500% over this time! And here is another good bit: it also has an attractive dividend yield of 6.5%.

The outlook for property stocks is a bit iffy for next year considering that supportive government policies are being withdrawn. Yet, over the long term, I think this is a winning stock, even if it sees ups and downs during the course of the business cycle. I bought the stock for the long term for this reason a few months ago. 

3i: impressive returns

Last is the investment company 3i, which has given the best returns among the three stocks in consideration here, of almost 700% over the last 10 years. It has also risen some 30% over the past year, though its P/E remains low at 4.5 times. If I consider its price to net asset value, the more popular indicator for measuring investment companies’ value, it does appear a bit overvalued.

Still, it recently delivered good results and is also optimistic about the future, which suggests to me that at a buoyant time for the stock markets, its share price could continue to rise. The stock is a buy for me.

Manika Premsingh owns shares of Persimmon. The Motley Fool UK has recommended Hikma Pharmaceuticals. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

See what £10,000 invested in dismal Diageo shares just 1 week ago is worth today

Diageo shares are all hangover and no fizz, says Harvey Jones. How long must investors wait before the FTSE 100…

Read more »

Rear view image depicting a senior man in his 70s sitting on a bench leading down to the iconic Seven Sisters cliffs on the coastline of East Sussex, UK. The man is wearing casual clothing - blue denim jeans, a red checked shirt, navy blue gilet. The man is having a rest from hiking and his hiking pole is leaning up against the bench.
Investing Articles

Up 1,146%! 7 things I’ve learned from the stunning Rolls-Royce share price comeback 

Harvey Jones has made a fair bit of money out of the booming Rolls-Royce share price, but he's also learned…

Read more »

Golden Retirees Heading to Beach
Investing Articles

4 steps to building a £38,456 retirement income with ISA shares

Investing £300 a month could deliver a life-changing cash stream in retirement with high-yield income shares. Royston Wild explains how.

Read more »

Content white businesswoman being congratulated by colleagues at her retirement party
Investing Articles

How investing in a Cash ISA could cost you a comfortable retirement

Cash ISAs are celebrated for the brilliant tax benefits they provide. But could focusing on them cost savers the chance…

Read more »

Young black woman in a wheelchair working online from home
Investing Articles

How much could Barclays shares pay in dividends by 2028?

Barclays is one of the FTSE 100's most popular dividend shares. How much could they provide over the next three…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

With a 6% yield and a P/E of just 7.4, is this share a screaming buy for a second income?

Mark Hartley looks at the second income potential of a popular UK dividend stock that still looks undervalued despite compelling…

Read more »

Investing Articles

Forget Nvidia! This ETF is booming inside my Stocks and Shares ISA

A thematic ETF inside this writer's ISA has more doubled the return of Nvidia stock so far in 2026. But…

Read more »

Shot of an young mixed-race woman using her cellphone while out cycling through the city
Investing Articles

These cheap FTSE 250 shares could deliver a £1,550 ISA income in just 12 months!

Searching for the best low-cost dividend stocks to buy? Royston Wild reveals two FTSE 250 property shares with yields above…

Read more »